Selexipag 400mcg Tablets

Selexipag 400mcg Tablets contain selexipag, a prescription medicine used to treat pulmonary arterial hypertension. Uptravi 400mcg is an established branded tablet used in specialist PAH treatment.

Customers searching for Selexipag 400mcg price, Uptravi 400mcg tablets, product availability or pharmacy supply should confirm current pricing, pack details and dispensing requirements with an authorized pharmacy.

Product Information

Why Choose Selexipag 400mcg Tablets?

• Recognized brand reference: Uptravi.

• Specified strength: 400 micrograms of selexipag.

• Established PAH treatment: Used under specialist supervision.

• Product verification: Confirm the strength, manufacturer and packaging before purchase.

• International supply enquiries: Check authorized pharmacy availability in your destination country.

Selexipag 400mcg Price and Ordering Information

The price of Selexipag 400mcg tablets varies by country, supplier, brand and pack size. Contact an authorized pharmacy to confirm the current Selexipag 400mcg price, Uptravi availability and dispensing requirements.

Before ordering, verify product registration, packaging, expiry date and prescription requirements. Selexipag should only be obtained through authorized supply channels.

Generic Selexipag 400mcg vs Uptravi 400mcg

Uptravi 400mcg is the established branded tablet containing selexipag. Other selexipag products should only be described as generic equivalents when their formulation and regulatory status support that claim in the destination market.

Confirm the active ingredient, tablet strength, manufacturer and local authorization before considering a substitution.

Selexipag 400mcg — Availability by Country

Selexipag treatment generally starts at 200mcg twice daily in adults, with dose increases of 200mcg twice daily at weekly intervals until the highest tolerated dose is reached. The 400mcg strength may therefore be used during titration or as part of an individualized maintenance regimen.

The prescribed dose depends on tolerability and the applicable product information. Do not independently increase, reduce or interrupt treatment.

Common adverse effects include headache, diarrhoea, nausea, jaw pain, flushing and muscle pain. Low blood pressure and other clinically significant adverse reactions may also occur.

Inform the prescribing specialist about other medicines, liver problems and significant adverse effects. Regular monitoring is required throughout treatment.